Author

S. L. Annett

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

T. Robson· 3 shared A. Kissenpfennig· 1 shared A. M. Curtis· 1 shared A. M. Rehill· 1 shared A. Short· 1 shared A. Yakkundi· 1 shared C. Campbell· 1 shared C. Drakeford· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

T. Robson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

GLYCOLYTIC REPROGRAMMING FUELS MYELOID CELL-DRIVEN HYPERCOAGULABILITY

A. M. Rehill, G. Leon, S. McCluskey, I. Schoen, Y. Hernandez-Santana, S. L. Annett, P. Klavina, T. Robson, A. M. Curtis, T. Renne, S. Hussey, J. S. O'Donnell, P. T. Walsh, R. J. Preston

This study shows inflammation-induced glycolytic reprogramming in myeloid cells drives hypercoagulability and antifibrinolytic activity, with potential therapeutic implications.

Journal of Thrombosis and Haemostasis · Feb 1, 2024Peer-reviewedImmunology

Dexamethasone promotes breast cancer stem cells in obese and not lean mice

S. L. Annett, O. Fox, D. Vareslija, T. Robson

This study shows dexamethasone increases breast cancer stem cells in obese mice but not lean mice, suggesting obesity enhances GC-induced cancer stemness through non-genomic signaling.

bioRxiv · Jun 18, 2021Cancer Biology

The immunophilin protein FKBPL and its peptide derivatives are novel regulators of vascular integrity and inflammation via NF-kappaB signaling

S. L. Annett, S. Spence, C. Garciarena, C. Campbell, M. Dennehy, C. Drakeford, J. Lai, J. Dowling, G. Moore, A. Yakkundi, A. Short, D. Sharpe, F. Furlong, J. O'Donnell, G. Cavalleri, , T. Robson

This paper identifies FKBPL and its peptides as regulators of vascular integrity and inflammation via NF-kappaB signaling, showing therapeutic potential in inflammatory diseases.

bioRxiv · Feb 24, 2021 · PreprintImmunology